Reversibly Inhibited Enzyme Mixture for PCR Specificity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current PCR methods face challenges in minimizing non-specific amplification and primer dimer formation, especially with limited starting material or multiple sequences, leading to reduced sensitivity and detection issues in diagnostic applications.

Innovation Solution

A composition or kit containing a thermostable DNA polymerase reversibly inhibited by chemical modification and another by non-covalent binding of a polyanion, allowing for simultaneous use in PCR to optimize enzyme activity over time, reducing non-specific binding and amplification of unwanted sequences.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Speed

If DNA polymerase is added at room temperature to enable immediate enzyme activity, then amplification speed is improved, but non-specific binding and primer dimer formation increase

Engineering Contradiction:
Improveamplification speedVSAvoidnon-specific binding and primer dimer formation
Core Design Contradiction:
SpeedVSObject-generated harmful factors

Solution Approach 1:

The DNA polymerase is pre-modified with a reactive group that covalently binds to the enzyme before the PCR reaction begins. This preliminary modification ensures the enzyme remains inactive at room temperature, preventing non-specific binding, while allowing rapid activation upon heating to the denaturation temperature.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The invention changes the temperature parameter to control enzyme activity. The DNA polymerase is designed to be inactive at room temperature (20-25°C) and becomes active only when heated to the DNA denaturation temperature (94-98°C). This parameter change resolves the contradiction by enabling fast activation without non-specific binding.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If DNA polymerase is heated to denaturation temperature before addition to activate the enzyme, then non-specific binding is reduced, but processing time and batch complexity increase

Engineering Contradiction:
Improvenon-specific bindingVSAvoidprocessing time
Core Design Contradiction:
Object-generated harmful factorsVSLoss of time

Solution Approach 1:

The invention merges the enzyme activation step with the DNA denaturation step. The DNA polymerase is added to the reaction mixture at room temperature along with other components, and both the enzyme and DNA are activated simultaneously by heating to the denaturation temperature at the start of the PCR cycles, eliminating separate activation steps.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The DNA polymerase is designed to self-activate upon heating to the denaturation temperature. The covalent modification with a reactive group creates a temperature-dependent activation mechanism where the enzyme automatically becomes active at the appropriate temperature without requiring external activation procedures.

Inventive Principle:
Principle #25Self-service

3Object-generated harmful factors

If chemically modified DNA polymerase is used to ensure temperature-dependent activation, then non-specific amplification is reduced, but complete reactivation may not be achieved and enzyme activity is reduced over time

Engineering Contradiction:
Improvenon-specific amplificationVSAvoidenzyme activity consistency
Core Design Contradiction:
Object-generated harmful factorsVSReliability

Solution Approach 1:

The invention uses a reactive group that forms a covalent bond with the DNA polymerase that is stable at room temperature but breaks at the DNA denaturation temperature (94-98°C). This parameter change ensures complete and consistent reactivation of the enzyme during each denaturation step, maintaining reliable enzyme activity throughout the PCR process.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The reactive group used to modify the DNA polymerase is designed to form a covalent bond that can be rapidly and completely reversed by the high temperature of DNA denaturation. This accelerated reversal ensures complete enzyme reactivation within the short denaturation time frame, maintaining consistent enzyme activity.

Inventive Principle:
Principle #38Strong oxidants (Accelerated oxidation)

4Speed

If non-covalently bound polyanion is used to inhibit polymerase at room temperature, then rapid activation upon heating is achieved, but non-specific amplification occurs when starting material is limited

Engineering Contradiction:
Improveactivation speedVSAvoidnon-specific amplification
Core Design Contradiction:
SpeedVSObject-generated harmful factors

Solution Approach 1:

The invention creates a composite enzyme structure by covalently attaching a reactive group to the DNA polymerase. This composite structure combines the DNA polymerase catalytic activity with a temperature-sensitive inhibitory moiety, creating a single molecule that provides both rapid activation and high specificity.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

The invention extracts the inhibitory function from a separate polyanion molecule and integrates it directly into the DNA polymerase structure through covalent bonding. This integration ensures that the inhibition and activation properties are inherent to the enzyme itself, providing more reliable control over non-specific amplification.

Inventive Principle:
Principle #2Taking out (Extraction)

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach ensures sufficient enzyme activity at the beginning and throughout PCR, minimizing chain breaks and non-specific amplification, thereby enhancing the specificity and sensitivity of DNA amplification, especially for longer sequences and low-template amounts.

Implementation Method 1

a thermostable DNA polymerase which is reversibly inhibited by chemical modification

Methodology Applied
Scientific EffectChemical modification: Chemical Bonding

Implementation Method 2

another thermostable DNA polymerase which is reversibly inhibited by non-covalent binding of a polyanion

Methodology Applied
Scientific EffectNon-covalent binding: Adsorption

Implementation Method 3

by heating the PCR batches to the melting temperature of double-stranded DNA were activated

Methodology Applied
Scientific EffectThermal activation: Heating

Data Source

PatentEP2002015B1Mixture of reversibly inhibited enzymes
Publication Date: 2013.12.04 QIAGEN GMBH
  • EP2002015B1 patent drawingFigure 1a
  • EP2002015B1 patent drawingFigure 1b
  • EP2002015B1 patent drawingFigure 1c

AI summary

The invention relates to composition or a kit containing an enzyme that is reversibly inhibited by means of a chemical modification and an enzyme which is reversibly inhibited using non-covalent binding, the use of a mixture of enzymes reversibly inhibited in such a manner for processing or multiplying polynucleotides, and a method for specifically amplifying DNA by simultaneously using both types of reversibly inhibited enzymes.